Jason Jalil

Jason Jalil serves as an HS Assistant Clinical Professor in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine, University of California, Los Angeles. His academic career demonstrates a significant research evolution spanning oncology immunology and geriatric psychiatry.

His primary research domains include:

• Geriatric psychiatry and dementia care
• Brain health in aging populations
• Cancer immunotherapy (particularly melanoma)
• CTLA4 blockade mechanisms
• Digital technology's neurological impacts
• Polypharmacy management in elderly patients

Dr. Jalil's publication history reveals a strategic research transition from 2008-2013 cancer immunology work with the Ribas laboratory to 2019-2022 geriatric psychiatry research. This shift reflects both personal academic development and broader trends in medical research priorities. His early work focused on tumor immunology mechanisms, while recent publications address practical clinical challenges in dementia care and cognitive health maintenance.

He maintains active collaborations across UCLA departments, particularly with:

• Dr. Antoni Ribas (Jonsson Comprehensive Cancer Center)
• Dr. Susan Bookheimer (neuroimaging expert)
• Dr. Pauline Wu (geriatric psychiatry)
• Dr. Stephen Chen (aging research)

His research has generated significant academic impact, with publications referenced in patents, clinical guidelines, news media, and social platforms. The 2020 paper on digital technology's brain health consequences has been particularly influential, accumulating 62 PubMed Central citations and substantial social media attention.